Search Results for "free ce"

In the years following their initial licensure, nurses will often pursue certification. Obtaining certification shows a nurse’s commitment to their profession, specialty, and patients. Along with showing their commitment, certifications validate a nurse’s qualification and knowledge of a specific area.

To measure the value of oncology nursing certification, scientists must look at the intrinsic, qualitative outcomes associated with nurses achieving certification in practice. The research for oncology nursing certification has largely focused on perceived benefits for nurses, their colleagues, and their institutions. Data suggest that certified oncology nurses feel validated in their knowledge, report personal satisfaction for undertaking and completing the certification process, and say that it enhanced their professional credibility.

The annual ONS Congress® is your opportunity to network and make one-on-one connections with your peers, learn from their research and clinical experiences, and further empower yourself to make strides in the field. At ONS Congress, you’ll have plenty of ways to cultivate your professional development and gain contact hours and points to fulfill your certification needs.

The ONS Bridge session, Re-Defining The Bell: Recognizing Milestones, occurring live on Thursday, September 14, 2023, at 10:15 am ET, will provide nurses in direct patient care with a deep dive into how to celebrate and support patients along their entire cancer trajectory.  

Debuting in human clinical trials just a decade ago, chimeric antigen receptor (CAR) T-cell therapy was quickly hailed as a breakthrough cancer treatment for certain hematologic cancers. Today, patients and providers have access to 22 U.S. Food and Drug Administration (FDA)–approved cellular and gene therapy products, and CAR T-cell therapy is available beyond large academic research centers.

Once abandoned because of dose-limiting toxicities, a novel chemotherapy drug is showing even more promise as a modified prodrug. In study results published in Science Advances, researchers demonstrated how turning DRP-104 into a prodrug enables it to kill more tumor cells and activate CD8+ T cells with a “markedly improved tolerability profile.”

In addition to two live session dates on September 12 and 14, 2023, registering for ONS Bridge allows additional access to our bonus day on September 13, 2023, featuring six live roundtable discussions.

For many RNs working in oncology settings, certification might seem like the next step for their career and their commitment to patient-centered care. It’s important to understand the process of certification, along with what resources are available to help them succeed.

Mrs. Brown (she/her) is a 70-year-old assigned female at birth with a history of diffuse large B-cell lymphoma (DLBCL) with central nervous system involvement. She received axicabtagene ciloleucel and tolerated the immune effector cell (IEC) infusion.